Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Brehm

Showing results (201-210 of 292) with videos related to

Pageof 30
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host diseaseSteve Pino, Michael A Brehm, Laurence Covassin-Barberis, et al.
Journal of Thrombosis and Haemostasis : JTH|June 26, 2016
Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC MiamiT Obser, M Ledford-Kraemer, F Oyen, et al.
ACS Applied Materials & Interfaces|July 24, 2018
Locally Controlled Cu-Ion Transport in Layered Ferroelectric CuInP<sub>2</sub>S<sub>6</sub>Nina Balke, Sabine M Neumayer, John A Brehm, et al.
Thrombosis and Haemostasis|March 7, 2014
von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factorM A Brehm, V Huck, C Aponte-Santamaría, et al.
The Journal of Clinical Investigation|May 9, 2017
mRNA-mediated glycoengineering ameliorates deficient homing of human stem cell-derived hematopoietic progenitorsJungmin Lee, Brad Dykstra, Joel A Spencer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2019
Prosurvival kinase PIM2 is a therapeutic target for eradication of chronic myeloid leukemia stem cellsLeyuan Ma, Magnolia L Pak, Jianhong Ou, et al.
Molecular Therapy. Nucleic Acids|November 21, 2013
Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized MiceErica B Schleifman, Nicole Ali McNeer, Andrew Jackson, et al.
ACS Applied Materials & Interfaces|August 19, 2020
Local Strain and Polarization Mapping in Ferrielectric MaterialsSabine M Neumayer, John A Brehm, Lei Tao, et al.
Blood Advances|September 7, 2022
A conformational transition of the D'D3 domain primes von Willebrand factor for multimerizationSophia Gruber, Achim Löf, Adina Hausch, et al.
Biophysical Journal|May 9, 2015
Force-sensitive autoinhibition of the von Willebrand factor is mediated by interdomain interactionsCamilo Aponte-Santamaría, Volker Huck, Sandra Posch, et al.
Pageof 30

Showing results (201-210 of 292) with videos related to

Sort By:
Pageof 30
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host diseaseSteve Pino, Michael A Brehm, Laurence Covassin-Barberis, et al.
Journal of Thrombosis and Haemostasis : JTH|June 26, 2016
Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC MiamiT Obser, M Ledford-Kraemer, F Oyen, et al.
ACS Applied Materials & Interfaces|July 24, 2018
Locally Controlled Cu-Ion Transport in Layered Ferroelectric CuInP<sub>2</sub>S<sub>6</sub>Nina Balke, Sabine M Neumayer, John A Brehm, et al.
Thrombosis and Haemostasis|March 7, 2014
von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factorM A Brehm, V Huck, C Aponte-Santamaría, et al.
The Journal of Clinical Investigation|May 9, 2017
mRNA-mediated glycoengineering ameliorates deficient homing of human stem cell-derived hematopoietic progenitorsJungmin Lee, Brad Dykstra, Joel A Spencer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2019
Prosurvival kinase PIM2 is a therapeutic target for eradication of chronic myeloid leukemia stem cellsLeyuan Ma, Magnolia L Pak, Jianhong Ou, et al.
Molecular Therapy. Nucleic Acids|November 21, 2013
Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized MiceErica B Schleifman, Nicole Ali McNeer, Andrew Jackson, et al.
ACS Applied Materials & Interfaces|August 19, 2020
Local Strain and Polarization Mapping in Ferrielectric MaterialsSabine M Neumayer, John A Brehm, Lei Tao, et al.
Blood Advances|September 7, 2022
A conformational transition of the D'D3 domain primes von Willebrand factor for multimerizationSophia Gruber, Achim Löf, Adina Hausch, et al.
Biophysical Journal|May 9, 2015
Force-sensitive autoinhibition of the von Willebrand factor is mediated by interdomain interactionsCamilo Aponte-Santamaría, Volker Huck, Sandra Posch, et al.
Pageof 30